571 related articles for article (PubMed ID: 19067849)
41. Chromosome 9 instability and alterations of p16 gene in squamous cell carcinoma of the lung and in adjacent normal bronchi: FISH and immunohistochemical study.
Dessy E; Rossi E; Berenzi A; Tironi A; Benetti A; Grigolato P
Histopathology; 2008 Mar; 52(4):475-82. PubMed ID: 18315600
[TBL] [Abstract][Full Text] [Related]
42. [The relationship between methylation of p16 INK 4/CDKN2 gene in promoter region and progress of squamous cell carcinoma of buccal mucosa].
Dong YY; Wang J; Dong FS; Wang X; Li HX; Gu HT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 May; 41(5):297-8. PubMed ID: 16784614
[TBL] [Abstract][Full Text] [Related]
43. Methylation and intratumoural heterogeneity of 14-3-3 sigma in oral cancer.
Bhawal UK; Tsukinoki K; Sasahira T; Sato F; Mori Y; Muto N; Sugiyama M; Kuniyasu H
Oncol Rep; 2007 Oct; 18(4):817-24. PubMed ID: 17786341
[TBL] [Abstract][Full Text] [Related]
44. Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue.
Krecicki T; Smigiel R; Fraczek M; Kowalczyk M; Sasiadek MM
J Laryngol Otol; 2004 Sep; 118(9):676-80. PubMed ID: 15509364
[TBL] [Abstract][Full Text] [Related]
45. Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors.
Martínez-Cruz AB; Santos M; Lara MF; Segrelles C; Ruiz S; Moral M; Lorz C; García-Escudero R; Paramio JM
Cancer Res; 2008 Feb; 68(3):683-92. PubMed ID: 18245467
[TBL] [Abstract][Full Text] [Related]
46. P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals.
Blokx WA; de Jong EM; de Wilde PC; Bulten J; Link MM; Ruiter DJ; van de Kerkhof PC
Mod Pathol; 2003 Sep; 16(9):869-78. PubMed ID: 13679450
[TBL] [Abstract][Full Text] [Related]
47. [Expression of tumor suppressor gene p53 and Rb in patients with epidermoid carcinoma of the head and neck].
Schipper JH; Kelker W
HNO; 1994 May; 42(5):270-4. PubMed ID: 8050915
[TBL] [Abstract][Full Text] [Related]
48. p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
Sharpless NE; Alson S; Chan S; Silver DP; Castrillon DH; DePinho RA
Cancer Res; 2002 May; 62(10):2761-5. PubMed ID: 12019151
[TBL] [Abstract][Full Text] [Related]
49. p16 gene alterations in locally advanced squamous cell carcinoma of the head and neck.
Wang D; Grecula JC; Gahbauer RA; Schuller DE; Jatana KR; Biancamano JD; Lang JC
Oncol Rep; 2006 Mar; 15(3):661-5. PubMed ID: 16465427
[TBL] [Abstract][Full Text] [Related]
50. The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system.
Tokman B; Gultekin SE; Sezer C; Alpar R
Saudi Med J; 2004 Dec; 25(12):1922-30. PubMed ID: 15711668
[TBL] [Abstract][Full Text] [Related]
51. The Rb family connects with the Tp53 family in skin carcinogenesis.
Lara MF; Paramio JM
Mol Carcinog; 2007 Aug; 46(8):618-23. PubMed ID: 17486638
[TBL] [Abstract][Full Text] [Related]
52. Deletions of p15 and p16 in schistosomal bladder cancer correlate with transforming growth factor-alpha expression.
Swellam M; El-Aal AA; AbuGabel KM
Clin Biochem; 2004 Dec; 37(12):1098-104. PubMed ID: 15589816
[TBL] [Abstract][Full Text] [Related]
53. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
[TBL] [Abstract][Full Text] [Related]
54. Expression of p53, p16 and cyclooxygenase-2 in esophageal cancer with tissue microarray.
Liu YS; Yu CH; Li L; Zhang BF; Fang J; Zhou Q; Hu Y; Li YM; Jun Gao H
J Dig Dis; 2007 Aug; 8(3):133-8. PubMed ID: 17650224
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG
Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420
[TBL] [Abstract][Full Text] [Related]
56. [Analysis of the correlation between genetic and immunohistochemical markers (RB1, p16 and p53 gene regultors of a cell cycle) in sporadic mammary gland carcinoma].
Nemtsova MV; Zemliakova VV; Kuznetsova EV; Babenko OV; Zavalishina LE; Andreeva IuIu; Bateva MV; Frank GA; Zaletaev DV
Arkh Patol; 2007; 69(2):3-6. PubMed ID: 17642181
[TBL] [Abstract][Full Text] [Related]
57. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM
Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501
[TBL] [Abstract][Full Text] [Related]
58. Is p16(INK4a) protein expression in oral ST lesions a reliable precancerous marker?
Greer RO; Meyers A; Said SM; Shroyer KR
Int J Oral Maxillofac Surg; 2008 Sep; 37(9):840-6. PubMed ID: 18606525
[TBL] [Abstract][Full Text] [Related]
59. Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma.
Bradley G; Irish J; MacMillan C; Mancer K; Witterick I; Hartwick W; Gullane P; Kamel-Reid S; Benchimol S
Oncogene; 2001 Feb; 20(5):654-8. PubMed ID: 11313998
[TBL] [Abstract][Full Text] [Related]
60. [The expression of P16, Rb and cyclin D1 and biological behavior of laryngeal cancer].
Dai S; Huang W; Gan X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Oct; 32(5):299-301. PubMed ID: 10743098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
